title: [Essential phospholipids in combined therapy of chronic circulatory insufficiency].
abstract: Essential phospholipids (essentiale-forte) was used in combined therapy of 36 patients with pronounced circulatory insufficiency and hepatic dysfunction. A 4-6-week course of this treatment 6 weeks after its termination resulted in good subjective response, positive changes in hemodynamics, intrahepatic cholestasis, synthetic function of the liver and lipid metabolism. The drug was well tolerated.
authors.affiliation: Department of Internal Diseases Propedeutics, MMA of IM Sechenov.
authors.forename: V S
authors.initials: VS
authors.lastname: Golochevskaia
authors.forename: E K
authors.initials: EK
authors.lastname: Baranskaia
authors.forename: I V
authors.initials: IV
authors.lastname: Trofimenko
authors.forename: N P
authors.initials: NP
authors.lastname: Balakhonova
authors.forename: I A
authors.initials: IA
authors.lastname: Burmakin
authors.forename: V I
authors.initials: VI
authors.lastname: Kop'ev
authors.forename: O O
authors.initials: OO
authors.lastname: Zadorozhnaia
mesh_terms: D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000975:Antioxidants; D002316:Cardiotonic Agents; D004232:Diuretics; D010713:Phosphatidylcholines; C011246:essential 303 forte
vernacular_title: Essentsial'nye fosfolipidy v kompleksnoí terapii khronicheskoí nedostatochnosti krovoobrashchenia.